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SOME years ago, in connection with work on the metabolism of carcinogenic
azo compounds, the method of excretion by the rat of a number of aromatic
amines was studied. A preliminary account of some of this work was given at
a meeting ofthe Biochemical Society (Elson, Goulden and Warren, 1946).
Many aromatic amines are excreted as ethereal sulphates of amino phenols,
and one of the aims of this work was to investigate the effects of the amines on
sulphur metabolism as had been done previously for a series of aromatic hydro-
carbons (Elson, Goulden and Warren, 1945). The investigation was concerned
therefore mainly with determining changes in the daily excretion of ethereal
sulphate, inorganic sulphate, neutral sulphur and of glucuronic acid in the urine
following administration of the aromatic amines.
It was hoped eventually to investigate more completely the metabolism of
individual amines andto characterise definitely theirmetabolites, butthisextended
investigation has not been possible in most cases. The subsequent discovery of
of the carcinogenic action in rats of a number of the amines, e.g. aminostilbenes
(Haddow, Harris, Kon and Roe, 1948; Elson, 1952a), 4-dimethylamino-diphenyl
(Miller, Miller, Sandin and Brown, 1949), benzidine (Spitz, Maguiganand Dobriner,
1950), and, in particular, 4-amino-diphenyl and 3: 2'-dimethyl-4-aminodiphenyl
by Walpole, Williams and Roberts (1952) and their suggestion that ortho hydroxy-
amines may be direct-acting carcinogens, has suggested the possibility of an
interesting relationship between our findings for the metabolism ofthese aromatic
amines and their carcinogenic action.
The purpose of the present paper therefore is to describe in more detail the
results of our metabolism studies and to discuss their possible significance in
relation to carcinogenesis.
EXPERIMENTAL
Animals
The experiments were carried out on male rats maintained on a high protein
diet (diet A, Elson 1952a). Groups of six rats were kept in one metabolism cage
and supplied with diet and water ad libitum. The daily excretion of glucuronic
acid, inorganic sulphate, ethereal sulphate, and in most cases neutral sulphur
was determined as described by Elson, Goulden and Warren (1945). This was
done for several days before administration of the amines dissolved in arachis
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oil, by intraperitoneal injection and the estimations were continued for several
days subsequently. In some cases, 1 ml. arachis oil was injected prior to the
control period of estimations preceding administration of the amine, but as this
was found to give no appreciable changes in amounts ofthe excretion components
estimated it was discontinued.
Detection offree and conjugated amines
In many cases the excretion of the amine was followed by a colorimetric
method for detection offree aromatic amino groups by diazotisation and coupling
with N-sulphato-ethyl-m-toluidine, as described by Elson and Warren (1944).
By the use of the " Spekker " photoelectric absorptiometer for measuring the
colour obtained with the untreated urine and the colour obtained after acid
hydrolysis of the urine, it was often possible to obtain an idea of the amount
of free and conjugated amine present. (An increase in the colour test after
hydrolysis probably indicates that some of the original amine has been acetylated
and excreted as the acetyl amino derivative, as is known to occur with drugs
such as sulphonamides, etc.)
RESULTS
The output of ethereal sulphates and glucuronides in the urine following
injection of aromatic amines is shown in Fig. 1. With several of the amines the
effect of more than one dose was investigated, and with some of them a large
dose resulted in excretion of both ethereal sulphates and glucuronides. When
the dose was reduced however, it was generally found that an increase of ethereal
sulphate alone, or ofglucuronide alone occurred, so that with moderate doses the
amine showed a preferential excretion either as ethereal sulphate or as glucuronide.
Fig. 1 shows the results obtained with these " preferential " doses.
A typical case where increased dosage results in excretion of glucuronide in
addition to the " preferential " ethereal sulphate is shown in Fig. 2 which gives
the results of acetanilide at doses of 20mg./100g. rat. and 9mg./100g. rat. The
inorganic sulphate excretion is also shown and clearly demonstrates the fall in
inorganic sulphate corresponding to the rise of ethereal sulphate.
Table I shows the mode ofexcretion ofthe amines in relation to their carcino-
genic properties. The probable nature of the principal metabolic products
is also suggested. In a number of cases the unconjugated metabolic products
have been isolated and characterised by various workers. The other suggestions
are based on general inferences considered in conjunction with the present results.
The percentage figures under some of the formulae refer to the amine estimated
colorimetrically by diazotisation and coupling with N-sulphato-ethyl-m-toluidine.
Increase in the intensity of this colour test after hydrolysis probably indicates
acetylation, and from the values before and after hydrolysis an estimate of the
relative percentage of free and acetylated amine present in the original urine
has been obtained.
From Fig. 1 it is seen that the amines fall clearly into two groups. The first
group consists of compounds containing a single benzene ring, viz. aniline, 4-
chloroaniline, phenetidine, dimethylaniline, and acetanilide, which are excreted
preferentially as ethereal sulphates. The second group consists of amines
excreted preferentially as glucuronides, and these are the ones containing two
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FIG. 1.-Ethereal sulphate and glucuronide excretion in rats followina adminriitrat
aromatic amnines.
*Toxicl1 rat died 3rd day after injection.
#Toxic-2 rats died 4th day after injection.
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benzene rings, viz. 4-amino-diphenyl, benzidine, 4-amino-stilbene, 4-acetylamino-
stilbene.
When the investigation was first started only 4-amino-stilbene had been
shown to produce tumours in the rat. Now however, benzidine has been shown
to be carcinogenic in this species (Spitz et al. 1950), dimethylamino-diphenyl was
found to be carcinogenic by Miller et al., (1949), and finally rat tumours have been
induced with 4-amino-diphenyl by Walpole et al. (1952). This compound has
also been shown to produce bladder tumours in dogs (Walpole, Williams and
Roberts, 1954). It " appears to be more effective as a bladder carcinogen in the
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FIG. 2.-Excretion of inorganic sulphate, glucuronic acid and ethereal sulphate in rats
treated with acetanilide.
Ordinate numbers represent mg.S for inorganic sulphate and ethereal sulphate;
each figure multiplied by 10 gives the amount of glucuronic acid.
dog than either benzidine or 2-acetylamino fluorene and at least as potent as
,f-naphthylamine ". In contrast, none of the aniline derivatives comprising the
first group (Fig. 1) (Table I) has been found to be carcinogenic.
DISCUSSION
Considering the mode of action of the carcinogenic aromatic amines it seems
most probable that it is their metabolites, produced during the course of the so-
called " detoxication " mechanism in the body, which constitute the real carcino-
genic agents. Perhaps some of the most convincing evidence for this view is the
failure of 2-naphthylamine, known to be responsible for production of bladder
tumours in man, to produce tumours when implanted into the bladders of mice
whereas its metabolite 2-amino-l-naphthol readily induces such tumours (Bonser,
Clayson, Jull and Pyrah, 1952).
In their work on the carcinogenic action of 4-amino-diphenyl and, more
particularly of 3: 2'-dimethyl-4-amino-diphenyl, Walpole et al. (1952) suggestedL. A. ELSON, F. GOULDEN AND F. L. WARREN
TABLx I.-Mode of Excretion of Aromatic Amines in Relation to Carcinogene8i&.
AMINE
(NH2
AN/LINE
Cl{-)NH2
4-CHL0OfOANILINE
C2H50-C)-NH2
PHENETIDINE
C2H50-CJ-NH. CO*CH3
PHENACErTIN
Q-N (CH3)2
D/METHYL ANILINE
EXCRETION DOSE AS
mg/lOOg.rat. Ethereal Glucuronic
sqIO.rt ulphate. acid.
7 25 + -
14-0 ++ slight
7-8 + -
PROBABLE NATURE OF PRINCIPAL
METABOLIC PRODUCTS.
NaSO3 0-Cj-NH2
cl{-(J}NH2
OSO3Na
20 ++ - C2H50{jNH.CO CH3
O SO3Na
(400%o)
20 ++ - C2H509-qNH COCH3
OQSO3Na
(40>%)
17 ++ slight NuSO3O-)-N (CH3)2
C2H50-Q-NH2
OSO3Na
(60Jo)
C2H5O-qNH2
OSO3Na
(60%h)
NaSO30-Q NH2
(s%)
C9-C-NH2
4-AMINO DIPHENYL
NH2 {-Cj-NH2
BENZ/DINE
C9-CH=CH-NH2
4-AMI/NO STILBENE
3-CH=CH-C)- NH CO CH3
4-ACETYLAMINO STILBENE
* CARCINOGENIC
8 6
16
85
19
47
- ++
+ ++
GLU O-Q--CJ-NH2
GLU-O O GLU
- ++ NH2 jNH2
-++ GLUO-GJCH:CHC<JNH2
GLU O-QCH=CH-Q-NH CO. CH3
(20%)
-++ GLUO-CoCHzCH-CNH2
GLU.O-00 CH=CH.Q,-NH-CO) CH3
(40ob)
GLU =Glucuronic acid
that ortho hydroxy amines may be direct-acting carcinogens, and Clayson (1953)
has put forward a working hypothesis for the mode ofcarcinogenesis of aromatic
amines which suggests that " (1) compounds which contain a hydroxyl and an
amino group ortho to each other in an aromatic system of two or more rings may be carcinogenic either in their own right or as a result of their further reaction;
(2) the reason why some aromatic amines induce tumours whereas others do not
is that the former are more readily converted in thebody toortho-hydroxy amines
than the latter ".
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It must be emphasised that this remains merely an hypotI and indeed
Clayson himself points out the need for further investigation' gd 'experimental
work both biological and biochemical. There is in fact, no eOvdence to suggest
that ortho hydroxylation is the only essential for carcinogenicitv in an aromatic
amine, or that para hydroxy aromatic amines cannot be carcino,inic. It would
for instance be extremely dangerous to assume that a blocked'kara position such
as occurs in phenacetin and most probably leads to metabolic-hydroxylation in
the ortho position to the amino group could incur a suggestion of carcinogenicity
in this drug. In fact Schmahl and Reiter (1954) in very"prolonged feeding
tests with rats during which a total dose of 22 g. ofphenacet'in was taken by each
rat found no evidence of a'ny carcinogenic effect of the drug.'' 'A similar case is
represented by 4-chloro-aniline which has been shown by' Elson and Spinks
(unpublished) to be excreted in the rat and the rabbit a the ortho hydroxy
derivative
NH2
OH
Cl
and prolonged feeding of 4-chloro-aniline to rats failed to'produce any,evidence
of its carcinogenicity.
Clearly other factors must also be involved in the carcinogenic potentialities
of aromatic amines, and the results described in this paper, although they must
be regarded rather in the nature of a preliminary approach. to the problem, do
at least suggest one other aspect, namely that notonly 'the nature ofthe hydoxy-
lated metabolite but also themethod ofconjugation may be ofprimaryimportance.
In the limited series of aromatic amines examined a sharp change in the "prefer-
ential " conjugation ofthe amine from the ethereal sulphate to giucuronide occeir
on passing from the simpler " one benzene ring " amines to the'more comptex
"two benzene ring " amines.' For the rat this change is accompanied by increased
generaltoxicity andwiththedevelopment ofcarcinogenic properties inthe amines.'
In considering thepossible significance ofpreferential excretion asglucuronides,
in this connection it was noted that 4-amino-phenol is excreted preferenti4illy as
glucuronide although aniline is excreted preferentially as the ethereal sutpklate
of 4-amino-phenol. It is not easy to see why, if the aniline is metabo sed
in the body to 4-amino-phenol it too should not be preferentially excreted as
glucuronide, and one might be tempted to speculate that ethereal sulphate con-
jugation and oxidation could take place almost simultaneously without liberation
of appreciable quantities of the toxic amino-phenol itself.
As for the significance of the glucuronide excretion, it has been suggested by
one ofus (Elson, 1952b) in connnectionwith the action ofthe enzymeglucuronidase
that " glucuronic acid formation and the role of glucuronidase in animal metabo-
lism maynot be exclusively concerned with the so-called detoxication mechanisms,
but may also be that of providing a' transfer mechanism for conveyance of a
fat-soluble but water insoluble substance such as a steroid hormone from one
organ in the body to others on which it is required to act. The substance is
transferred by being converted into a water soluble glucuronide, which may no
8
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longer show hormone activity, and this is carried in the blood stream, and, in
this water soluble form, is able to enter the cells of various organs. The active
hormone is then liberated in situ in that organ by means of the glucuronidase
present in the cell ". The carcinogenic aromatic amines could thus become
involved in this process in respect of their tendency to glucuronide formation,
being transferred as their water soluble glucuronides into the cells of the various
organs and the active carcinogen liberated by the glucuronidase present in the
cells.
An indication of the possible significance of glucuronides in carcinogenesis is
given by Boyland, Wallace and Williams (1955) who found that the ethereal
sulphate of 2-amino-L-naphthol is not hydrolysed by the sulphatases ofrat kidney,
takadiastase, or human urine, whereas 2-amino-1-naphthyl glucosiduronic acid
is hydrolysed by fl-glucuronidase. The actual carcinogenic agent concerned in
induction of cancer of the bladder in man by 2-naphthylamine is believed to be
2-amino-1-naphthol released from conjugates in the urine. The carcinogenic
amino naphthol would not, according to their findings, be liberated from 2-amino-
1-naphthol sulphuric ester but would be produced from 2-amino-1-naphthyl
glucosiduronic acid. The glucuronide is therefore probably an essential inter-
mediate me'.abolite in induction of bladder cancer by 2-naphthylamine, and this
idea receives strong support from the findings ofAllen, Boyland, Dukes, Horning,
and Watson (1957) that of five metabolites of 2-naphthylamine tested by direct
implantation in the bladders ofmice, the only one to induce tumours was 2-amino-
1-naphthylglucosiduronic acid.
SUMMARY
Aromatic amines administered to rats are excreted as ethereal sulphates or
as glucuronides of amino phenols. Although with large doses increase in the
urinary excretion both of ethereal sulphate and of glucuronic acid can occur,
withlowerdoses apreferentialexcretioneitheras etherealsulphateorasglucuronide
is obtained.
The simpler " one benzene ring " aromatic amines, aniline, 4-chloroaniline,
phenetidine, phenacetin, dimethylaniline, and acetanilide are excreted by the
rat preferentially as ethereal sulphates whereas the " two benzene ring " amines,
4-aminodiphenyl, benzidine, 4-aminostilbene and 4-acetylaminostilbene are
excreted preferentially as glucuronides.
All the amines of this latter group excreted as glucuronides have now been
shown to be carcinogenic. Those of the former group, excreted as ethereal
sulphates do not appear to be carcinogenic.
Thepossible significanceofexcretion asglucuronide inrelation to carcinogenesis
is discussed.
This work has been supported by grants to the Chester Beatty Research
Institute (Institute ofCancer Research: Royal Cancer Hospital) from the British
Empire Cancer Campaign, the Jane Coffin Childs Memorial Fund for Medical
Research, the Anna FullerFund, and the National Cancer Institute ofthe National
Institutes of Health, U.S. Public Health Service.
114METABOLISM OF AROMATIC AMINES 115
REFERENCES
ALLEN, M. J., BOYLAND, E., DUKES, C. E., HORNrNG, E. S. AND WATSON, J. G.-(1957)
Brit. J. Cancer, 11, 212.
BONSER, G. M., CLAYSON, D. B., JULL, J. W. AND PYRAH, L. N.-(1952) Ibid., 6, 412.
BOYLAND, E., WALLACE, D. M. AND WILLIAMAS, D. C.-(1955) Ibid., 9, 62.
CLAYSON, D. B.-(1953) Ibid., 7, 460.
ELSON, L. A.-(1952a) Ibid., 6, 392.-(1952b) 'Ciba Foundation Colloquia on Endo-
crinology'. London (J. & A. Churchill), 1, 284.
Idem, GOULDEN, F. AND WARREN, F. L.-(1945) Biochem. J., 39, 301.-(1946) Ibid.,
40, XXIX.
Idem., AND WARREN, F. L.-(1944) Ibid., 38, 217.
HADDOW, A., HARRIS, R. J. C., KON, G. A. R. AND ROE, E. M. F.-(1948) Phil. Trans.
A, 241, 147.
MILLER, E. C., MILLER, J. A., SANDIN, R. B. AND BROWN, R. K.-(1949) Cancer Res.,
9, 504.
SCHMAEL, D. AND REITER, A.-(1954) Arzneimittel Forsch., 4, 404.
SPITZ, S., MAGUIGAN, W. H. AND DOBRINER, K.-(1950) Cancer, 3, 789.
WALPOLE, A. L., WILLIAMS, M. H. C. AND ROBERTS, D. C.-(1952) Brit. J. indust. Med.,
9, 255.-(1954) Ibid., 11, 105.